Search research articles
Contact Us
Filters
Showing results (101-110 of 186) with videos related to
Page
of 19
Sort By:
BMC Cancer
|
August 22, 2023
NEXUS trial: a multicenter phase II clinical study evaluating the efficacy and safety of the perioperative use of encorafenib, binimetinib, and cetuximab in patients with previously untreated surgically resectable BRAF V600E mutant colorectal oligometastases
Shin Kobayashi, Hideaki Bando, Akinobu Taketomi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 14, 2019
Response to Anti-EGFR Therapy in Patients with BRAF non-V600-Mutant Metastatic Colorectal Cancer
Rona Yaeger, Daisuke Kotani, Sebastián Mondaca, et al.
BMC Cancer
|
April 22, 2020
TENERGY: multicenter phase II study of Atezolizumab monotherapy following definitive Chemoradiotherapy with 5-FU plus Cisplatin in patients with unresectable locally advanced esophageal squamous cell carcinoma
Hideaki Bando, Daisuke Kotani, Takahiro Tsushima, et al.
Cancer Immunology Research
|
December 12, 2024
Mathematical Modeling Predicts Optimal Immune Checkpoint Inhibitor and Radiotherapy Combinations and Timing of Administration
Shunsuke A Sakai, Koichi Saeki, SungGi Chi, et al.
British Journal of Cancer
|
May 5, 2025
Prognostic significance of circulating tumor DNA alterations in advanced renal cell carcinoma from SCRUM-Japan MONSTAR-SCREEN: a nationwide genomic profiling project
Taigo Kato, Masaki Shiota, Koshiro Nishimoto, et al.
Nature Reviews. Gastroenterology & Hepatology
|
March 15, 2024
Future direction of total neoadjuvant therapy for locally advanced rectal cancer
Yoshinori Kagawa, J Joshua Smith, Emmanouil Fokas, et al.
Clinical Colorectal Cancer
|
March 14, 2018
A Multicenter Clinical Phase II Study of FOLFOXIRI Plus Bevacizumab as First-line Therapy in Patients With Metastatic Colorectal Cancer: QUATTRO Study
Eiji Oki, Takeshi Kato, Hideaki Bando, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 1, 2022
Rapid Screening Using Pathomorphologic Interpretation to Detect BRAFV600E Mutation and Microsatellite Instability in Colorectal Cancer
Satoshi Fujii, Daisuke Kotani, Masahiro Hattori, et al.
Clinical Colorectal Cancer
|
March 29, 2024
Safety and Efficacy of Encorafenib, Binimetinib, and Cetuximab for BRAF<sup>V600E</sup>-Mutant Metastatic Colorectal Cancer: Results of the Japanese Expanded Access Program
Daisuke Kotani, Atsuo Takashima, Takeshi Kato, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 19, 2024
Efficacy of immune checkpoint inhibitors for metastatic colorectal cancer with microsatellite instability in second or latter line using synthetic control arms: A non-randomised evaluation
Romain Cohen, Morteza Raeisi, Benoist Chibaudel, et al.
Page
of 19
Search research articles
Search
Showing results (101-110 of 186) with videos related to
Sort By:
Page
of 19
BMC Cancer
|
August 22, 2023
NEXUS trial: a multicenter phase II clinical study evaluating the efficacy and safety of the perioperative use of encorafenib, binimetinib, and cetuximab in patients with previously untreated surgically resectable BRAF V600E mutant colorectal oligometastases
Shin Kobayashi, Hideaki Bando, Akinobu Taketomi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 14, 2019
Response to Anti-EGFR Therapy in Patients with BRAF non-V600-Mutant Metastatic Colorectal Cancer
Rona Yaeger, Daisuke Kotani, Sebastián Mondaca, et al.
BMC Cancer
|
April 22, 2020
TENERGY: multicenter phase II study of Atezolizumab monotherapy following definitive Chemoradiotherapy with 5-FU plus Cisplatin in patients with unresectable locally advanced esophageal squamous cell carcinoma
Hideaki Bando, Daisuke Kotani, Takahiro Tsushima, et al.
Cancer Immunology Research
|
December 12, 2024
Mathematical Modeling Predicts Optimal Immune Checkpoint Inhibitor and Radiotherapy Combinations and Timing of Administration
Shunsuke A Sakai, Koichi Saeki, SungGi Chi, et al.
British Journal of Cancer
|
May 5, 2025
Prognostic significance of circulating tumor DNA alterations in advanced renal cell carcinoma from SCRUM-Japan MONSTAR-SCREEN: a nationwide genomic profiling project
Taigo Kato, Masaki Shiota, Koshiro Nishimoto, et al.
Nature Reviews. Gastroenterology & Hepatology
|
March 15, 2024
Future direction of total neoadjuvant therapy for locally advanced rectal cancer
Yoshinori Kagawa, J Joshua Smith, Emmanouil Fokas, et al.
Clinical Colorectal Cancer
|
March 14, 2018
A Multicenter Clinical Phase II Study of FOLFOXIRI Plus Bevacizumab as First-line Therapy in Patients With Metastatic Colorectal Cancer: QUATTRO Study
Eiji Oki, Takeshi Kato, Hideaki Bando, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 1, 2022
Rapid Screening Using Pathomorphologic Interpretation to Detect BRAFV600E Mutation and Microsatellite Instability in Colorectal Cancer
Satoshi Fujii, Daisuke Kotani, Masahiro Hattori, et al.
Clinical Colorectal Cancer
|
March 29, 2024
Safety and Efficacy of Encorafenib, Binimetinib, and Cetuximab for BRAF<sup>V600E</sup>-Mutant Metastatic Colorectal Cancer: Results of the Japanese Expanded Access Program
Daisuke Kotani, Atsuo Takashima, Takeshi Kato, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 19, 2024
Efficacy of immune checkpoint inhibitors for metastatic colorectal cancer with microsatellite instability in second or latter line using synthetic control arms: A non-randomised evaluation
Romain Cohen, Morteza Raeisi, Benoist Chibaudel, et al.
Page
of 19